close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Biofrontera Inc. - Common Stock (NQ:BFRI)

0.7201 -0.0148 (-2.01%)
Streaming Delayed Price Updated: 4:00 PM EST, Dec 17, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Biofrontera Inc. - Common Stock

< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
News headline image
Biofrontera Inc. Reports First Quarter 2023 Financial Results and Provides a Business Update
Via ACCESSWIRE
News headline image
Biofrontera Inc. Announces Resignation of CEO
Via ACCESSWIRE
News headline image
Biofrontera Earnings Preview ↗
 
Via Benzinga
News headline image
Biofrontera Inc. Announces New Secured Line of Credit up to $6.5 Million
Via ACCESSWIRE
News headline image
Biofrontera Collaborates with The Skin Cancer Foundation to Raise Awareness of Skin Cancer Prevention
Via ACCESSWIRE
News headline image
Biofrontera Inc. to Report First Quarter 2023 Financial Results on May 12, 2023
Via ACCESSWIRE
News headline image
Biofrontera Inc. Announces Last Patient Out in Phase I Study to Evaluate Safety and Tolerability in Treating Actinic Keratosis Using 3 Tubes of Ameluz(R)
Via ACCESSWIRE
News headline image
Biofrontera Inc. to Attend 2023 American Academy of Dermatology Annual Meeting
Via ACCESSWIRE
News headline image
Biofrontera's Earnings Outlook ↗
 
Via Benzinga
News headline image
Biofrontera Inc. Makes Transformative Investment in Its' Dermatology Salesforce
Via ACCESSWIRE
News headline image
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday ↗
The biggest pre-market stock movers for Friday are ready to go as we dive into the latest news for investors this morning! 
Via InvestorPlace
News headline image
Why Sarepta Therapeutics Shares Are Trading Lower By Around 19%; Here Are 20 Stocks Moving Premarket ↗
Gainers Enzo Biochem, Inc. (NYSE: ENZ) shares rose 89.9% to $2.26 in pre-market trading after the company announced it will sell its clinical laboratory to Labcorp. 
Via Benzinga
News headline image
CORRECTING AND REPLACING: Biofrontera Inc. Reports Fourth Quarter and Record Full-year 2022 Financial Results
Via ACCESSWIRE
Biofrontera's Return On Capital Employed Overview ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Wednesday's After-Market Session ↗
 
Via Benzinga
News headline image
Biofrontera Inc. Reports Fourth Quarter and Record Full-year 2022 Financial Results
Via ACCESSWIRE
News headline image
Earnings Scheduled For March 8, 2023 ↗
Companies Reporting Before The Bell • Daktronics (NASDAQ:DAKT) is expected to report quarterly earnings at $0.00 per share on revenue of $164.68 million. 
Via Benzinga
News headline image
Biofrontera, Inc. to Present at the 35th Annual ROTH Conference on March 13, 2023
Via ACCESSWIRE
News headline image
12 Health Care Stocks Moving In Friday's After-Market Session ↗
 
Via Benzinga
News headline image
Biofrontera Inc. to Report Fourth Quarter and Full Year 2022 Financial Results on March 8, 2023
Via ACCESSWIRE
12 Health Care Stocks Moving In Wednesday's After-Market Session ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Thursday's After-Market Session ↗
 
Via Benzinga
News headline image
Biofrontera Inc. Announces First Patient Dosed in Pivotal Phase 3 Clinical Study Evaluating Ameluz(R)-PDT for the Treatment of Actinic Keratosis on the Extremities, Neck and Trunk
Via ACCESSWIRE
News headline image
Biofrontera Inc. Announces Preliminary Revenues for the Fourth Quarter and Full Year 2022
Via ACCESSWIRE
News headline image
Biofrontera Inc. to Participate in Benchmark’s 11th Annual Discovery One-on-One Investor Conference
From Biofrontera Inc.
Via GlobeNewswire
News headline image
BIOFRONTERA INC. TO PARTICIPATE IN RENMARK’S VIRTUAL NON-DEAL ROADSHOW SERIES ON WEDNESDAY, NOVEMBER 30, MONDAY, DECEMBER 5, FRIDAY, DECEMBER 9, AND MONDAY, DECEMBER 19 2022
From Biofrontera Inc.
Via GlobeNewswire
News headline image
Why ObsEva Shares Are Trading Higher By Over 70%; Here Are 21 Stocks Moving Premarket ↗
Gainers ObsEva SA (NASDAQ: OBSV) shares rose 71.9% to $0.2848 in pre-market trading after the company reported the sale of Ebopiprant license agreement to XOMA for up to $113 million. 
Via Benzinga
News headline image
Biofrontera to Launch Phase 3 Clinical Study Evaluating Ameluz®-PDT for the Treatment of Actinic Keratosis on the Extremities, Neck and Trunk
From Biofrontera Inc.
Via GlobeNewswire
News headline image
Biofrontera Inc. Reports Third Quarter 2022 Financial Results and Provides a Business Update
From Biofrontera Inc.
Via GlobeNewswire
News headline image
Biofrontera Inc. to Report Third Quarter Financial Results on November 14, 2022
From Biofrontera Inc.
Via GlobeNewswire
< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at $3.75/week.

Subscribe Today